2023 Poster Presentations
Preliminary List as of November 18, 2022
2bind GmbH
Biophysical Characterizations Supporting Developability and Formulation Screens of Antibodies
908 Devices
Enabling Real-Time Process Control: Automated Glucose Feeding Based on Online Measurement
A-Alpha Bio
ML-Guided Antibody Optimization of a SARS-CoV-2 Binding Antibody Enabled by AlphaSeq
Absolute Antibody
Comparing Potential Bispecific Formats of Trastuzumab and a Humanized OKT3
Absolute Antibody
Prometheus 2.0™: Engineering Manufacturable Humanized Antibodies from Diverse Sources Including Rabbit, Avian and Camelid Antibodies
ACROBiosystems, Inc.
Selection and Evaluation of Ancillary Materials for Cell and Gene Therapy Research
Ajinomoto Co., Inc.
ADC Therapeutic Window Enhancement Based on the Site-Specific Conjugation Platform: AJICAP Conjugation
Ajinomoto Co., Inc.
Novel Format Conjugates and Multi-Specific Antibodies Produced by Chemical Site-Specific Conjugation: AJICAP®
Ajinomoto Co., Inc.
From Peptides and Small Proteins to MAB, Ajinomoto's Proprietary Microbial Platform for Pharmaceutical Protein Production
Biotage
Automated Plasmid Prep and Optimized Protein Separation Using PhyTip Columns
FairJourney Biologics
Biophysical Characterization Approaches for Developability Assessment in Antibody Discovery
FyoniBio GmbH
Select Your Expression Host Right! - A Comprehensive View on Biopharmaceutical Production in CHOnamite vs Human GEX Host Cell Lines
Immunos Therapeutics
A Stabilized HLA-B57 Open Format (IOS-1002) Binding to LILRB1, LILRB2 and KIR3DL1 Induces Potent Anti-Tumor Efficacy
Immuto Scientific
In Vivo, Rapid Epitope and Paratope Mapping with Single Amino Acid Resolution
Immuto Scientific
In-Vivo Structural Analysis and Epitope Mapping of Membrane Proteins In-Solution with Amino-Acid Resolution and High-Throughput
Institute of Basic Science
Contrastive Learning for Antibody Representations and Antibody Classification Targeting Pathogenic Viruses
Just - Evotec Biologics
Practical Application of Machine-Learned Antibody Discovery Libraries
KANEKA Corporation
Downstream Process Intensification for AAV Using a Novel Impurity Removal Technology
Kyung Hee University
Cytosolic MicroRNA-Inducible Nuclear Translocation of Cas9 Protein for Disease-Specific Genome Modification
Lonza
A High Performing Easy-to-Use Media and Feed System for CHOK1SV GS-KO® Cell Lines-Based Product Manufacturing
MassBiologics
Development of a ddPCR Based Relative Potency Assay for APB-102
National Institutes of Health, National Heart, Lung, and Blood Institute
Expression and Purification of Obp44a with the Aids of LC-MS and NMR
Oswaldo Cruz Foundation (Fiocruz)
The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19 After 2 Years of the Pandemic
ProteinSimple, a Bio-Techne brand
High Speed and High Throughput CE-SDS Analysis with the Maurice Turbo CE-SDS Assay
ProteinSimple, a Bio-Techne brand
Novel icIEF Fractionation Coupled with Different MS Systems for Rapid Charge Variant Characterization of Therapeutic Antibodies
RevolKa, Ltd.
Machine-Learning Guided Mutagenesis for Directed Evolution of Recombinant Proteins
Sartorius Stedim Cellca GmbH
Strategies to Remove Single Cell Cloning from Genetic Knock Out Screens in Host Cell Line Engineering
Sogang University
Metal-Mediated Protein Oligomerization Using a Genetic Code Expansion Technique
SoonChunHyang University
Suppression of MyD88- and TRIF-Dependent Signaling Pathways of TLRs by Epoxomicin
Texas A&M University
Thermostable Raman Interaction Profiling (TRIP)
Tosoh Corporation
A Novel Analytical Column Using Adeno-Associated Virus Receptor (AAVR)
U.S. Food and Drug Administration
Size Dependent Toxicity of Engineered Nanoparticle Immunoglobulin Corona in TNFα-Stimulated Endothelial Cells: A Model for Investigation of Protein Particle's Biological Effects
Université catholique de Louvain
A Unique Screening System to Develop E. coli Mutants for the Efficient Production of Difficult to Express Therapeutic Proteins
Wonkwang University
Designing and Immunogenicity Assessment of a Novel mRNA SARS-CoV2 Vaccine Candidate